​​Last Friday, President Trump unveiled his administration's blueprint to lower prescription drug prices, which also solicits input on potential actions the Department of Health and Human Services (HHS) may take to improve competition and negotiation and lower costs. On Monday, HHS issued a policy statement and r​equest for information (RFI) on ways to lower drug prices and reduce out-of-pocket costs for consumers. HHS identified four priority challenges related to high drug prices and four overarching strategies it will pursue to address those challenges. HHS also seeks feedback on specific proposals and input on a wide range of questions related to the underlying factors contributing to high and rising drug costs. Stakeholders have 60 days to provide comments in response to the RFI.